The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy.
T. Cigler
No relevant relationships to disclose
M. J. Higgins
No relevant relationships to disclose
J. Szymonifka
No relevant relationships to disclose
A. H. Partridge
No relevant relationships to disclose
J. A. Ligibel
No relevant relationships to disclose
D. Finkelstein
No relevant relationships to disclose
S. E. Come
No relevant relationships to disclose
P. D. Ryan
No relevant relationships to disclose
P. E. Goss
No relevant relationships to disclose